Skip to main content
SpringerLink
Log in

Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background/Aims

The present study evaluated the clinical efficacy and pharmacokinetics of microemulsion cyclosporine A (ME-CyA) with modification from postprandial to preprandial administration in adult patients with refractory nephrotic syndrome.

Methods

We investigated 19 patients with refractory nephrotic syndrome who had been switched from the postprandial administration of ME-CyA to preprandial administration. The pharmacokinetics of ME-CyA were also evaluated before and 6 months after switching from postprandial to preprandial administration by serial measurement of the blood CyA concentration in 10 patients.

Results

This study showed that 16 of 19 patients (84%) displayed an improvement in their clinical condition or continued to maintain remission after switching from post- to preprandial administration. In particular among 14 patients with minimal change nephrotic syndrome (MCNS) in this study, 13 patients maintained or achieved remission under preprandial ME-CyA administration. Only three of 10 patients with postprandial administration showed a peak concentration> 500 ng/ml within 1–2 h after administration, while with preprandial administration, nine of 10 patients showed this good absorption profiles. This effectiveness of preprandial administration seems to be dependent on the improved pharmacokinetics with the increase of area under the curve from 0–4 h (AUC0–4) and peak concentration. There were no statistical differences in the mean daily doses of ME-CyA between both administration periods. No ME-CyA-induced nephrotoxicity or other harmful events were encountered throughout the study.

Conclusion

The preprandial administration of ME-CyA results in a good pharmacokinetic profile and is useful for management of refractory nephrotic syndrome in adults, particularly in patients with MCNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tanaka H, Nakahata T, Ito E. Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome. Pediatr Nephrol. 2004;19:1055–8.

    Article  PubMed  Google Scholar 

  2. Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, et al. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Clin Ther. 2004;26:1411–8.

    Article  CAS  PubMed  Google Scholar 

  3. Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, et al. More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy. 2005;25:52–8.

    Article  CAS  PubMed  Google Scholar 

  4. Mraz W, Muller C, Molnar B, Knedel M. Analysis of cyclosporin A (CsA) concentrations by fluorescence polarization immunoassay (FPIA): comparison with radio immunoassay (RIA) and liquid chromatography (HPLC). Transplant Proc. 1989;21:885–7.

    CAS  PubMed  Google Scholar 

  5. Dalere GM, Lum BL, Cooney GF, Wong-Chin M. Comparison of three methods for cyclosporine area under the curve monitoring calculations. Ther Drug Monit. 1995;17:305–7.

    Article  CAS  PubMed  Google Scholar 

  6. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59:1484–90.

    Article  CAS  PubMed  Google Scholar 

  7. Filler G. How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored? Nephrol Dial Transplant. 2005;20:1032–4.

    Article  CAS  PubMed  Google Scholar 

  8. Kung L, Batiuk TD, Palomo-Pinon S, Noujaim J, Helms LM, Halloran PF. Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am J Transplant. 2001;1:325–33.

    Article  CAS  PubMed  Google Scholar 

  9. Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation. 1999;68:1356–61.

    Article  CAS  PubMed  Google Scholar 

  10. Rainiene T, Papinigiene L, Laurinavicius A. [Nephrotoxicity of cyclosporin A after kidney transplantation]. Medicina (Kaunas). 2003;39(Suppl 1):161–5.

    Google Scholar 

  11. Tarantino A, Passerini P, Campise M, Bonizzoni E, Ceccarini F, Montagnino G, et al. Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose? Transplantation. 2004;78:675–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan

    Sayuri Shirai, Takashi Yasuda, Hiroki Tsuchida, Shingo Kuboshima, Yusuke Konno, Yoshinori Shima, Takeo Sato & Kenjirou Kimura

  2. Department of Pharmacy, St. Marianna University School of Medicine, Kawasaki, Japan

    Shigeo Hatta & Keisou Masuhara

Authors
  1. Sayuri Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroki Tsuchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shingo Kuboshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yusuke Konno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshinori Shima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takeo Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shigeo Hatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keisou Masuhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kenjirou Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sayuri Shirai.

About this article

Cite this article

Shirai, S., Yasuda, T., Tsuchida, H. et al. Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clin Exp Nephrol 13, 123–129 (2009). https://doi.org/10.1007/s10157-008-0112-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-008-0112-z

Keywords

Search

Navigation